Skip to main content
. 2020 Aug;23(8):990–998. doi: 10.22038/ijbms.2020.40859.9650

Table 4.

Hepatocyte insulin receptor binding constant and capacity (mol /mg protein)

Groups K1
(×108)		 K2
(×106)		 Q1
（×1010）		 Q2
(×1013)
Normal control
Diabetic control
Low dose
Medium dose
High dose		 5.40±0.11*
3.60±0.10
3.72±0.12
4.19±0.39*
4.62±0.33 *		 1.44±0.09*
0.76±0.09
0.81±0.11
0.95±0.07*
1.14±0.10*		 6.83±0.28*
3.91±0.26
3.96±0.31
4.79±0.28*
5.11±0.30*		 10.52±0.42*
6.04±0.32
6.01±0.43
7.25±0.42*
8.06±0.39*

Data are means±SD unless otherwise indicated, (n=10).

*Compared with diabetic control group, P<0.05